Literature DB >> 17160895

Deletions in CCM2 are a common cause of cerebral cavernous malformations.

Christina L Liquori1, Michel J Berg, Ferdinando Squitieri, Tracey P Leedom, Louis Ptacek, Eric W Johnson, Douglas A Marchuk.   

Abstract

Cerebral cavernous malformations (CCMs) are vascular abnormalities of the brain that can result in a variety of neurological disabilities, including hemorrhagic stroke and seizures. Mutations in the gene KRIT1 are responsible for CCM1, mutations in the gene MGC4607 are responsible for CCM2, and mutations in the gene PDCD10 are responsible for CCM3. DNA sequence analysis of the known CCM genes in a cohort of 63 CCM-affected families showed that a high proportion (40%) of these lacked any identifiable mutation. We used multiplex ligation-dependent probe analysis to screen 25 CCM1, -2, and -3 mutation-negative probands for potential deletions or duplications within all three CCM genes. We identified a total of 15 deletions: 1 in the CCM1 gene, 0 in the CCM3 gene, and 14 in the CCM2 gene. In our cohort, mutation screening that included sequence and deletion analyses gave disease-gene frequencies of 40% for CCM1, 38% for CCM2, 6% for CCM3, and 16% with no mutation detected. These data indicate that the prevalence of CCM2 is much higher than previously predicted, nearly equal to CCM1, and that large genomic deletions in the CCM2 gene represent a major component of this disease. A common 77.6-kb deletion spanning CCM2 exons 2-10 was identified, which is present in 13% of our entire CCM cohort. Eight probands exhibit an apparently identical recombination event in the CCM2 gene, involving an AluSx in intron 1 and an AluSg distal to exon 10. Haplotype analysis revealed that this CCM2 deletion occurred independently at least twice in our families. We hypothesize that these deletions occur in a hypermutable region because of surrounding repetitive sequence elements that may catalyze the formation of intragenic deletions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17160895      PMCID: PMC1785317          DOI: 10.1086/510439

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  23 in total

1.  Detecting exon deletions and duplications of the DMD gene using Multiplex Ligation-dependent Probe Amplification (MLPA).

Authors:  Kent K S Lai; Ivan F M Lo; Tony M F Tong; Lydia Y L Cheng; Stephen T S Lam
Journal:  Clin Biochem       Date:  2006-01-17       Impact factor: 3.281

Review 2.  Cerebral cavernous malformations: mutations in Krit1.

Authors:  D J Verlaan; W J Davenport; H Stefan; U Sure; A M Siegel; G A Rouleau
Journal:  Neurology       Date:  2002-03-26       Impact factor: 9.910

3.  Computational and experimental analyses reveal previously undetected coding exons of the KRIT1 (CCM1) gene.

Authors:  T Sahoo; E Goenaga-Diaz; I G Serebriiskii; J W Thomas; E Kotova; J G Cuellar; J M Peloquin; E Golemis; F Beitinjaneh; E D Green; E W Johnson; D A Marchuk
Journal:  Genomics       Date:  2001-01-01       Impact factor: 5.736

4.  Cerebral cavernous malformations. Incidence and familial occurrence.

Authors:  D Rigamonti; M N Hadley; B P Drayer; P C Johnson; K Hoenig-Rigamonti; J T Knight; R F Spetzler
Journal:  N Engl J Med       Date:  1988-08-11       Impact factor: 91.245

5.  Cavernous angiomas of the nervous system in Italy: clinical and genetic study.

Authors:  F Squitieri; V Maglione; M G Buzzi; E Nargi; A Novelletto; M Cannella; M Simonelli; C Colonnese; P Simonelli; G Innocenzi; F M Gagliardi; R Caruso; G Ragona; G P Cantore
Journal:  Neurol Sci       Date:  2000-06       Impact factor: 3.307

6.  Angiographically occult vascular malformations: a correlative study of features on magnetic resonance imaging and histological examination.

Authors:  F H Tomlinson; O W Houser; B W Scheithauer; T M Sundt; H Okazaki; J E Parisi
Journal:  Neurosurgery       Date:  1994-05       Impact factor: 4.654

7.  CCM2 mutations account for 13% of cases in a large collection of kindreds with hereditary cavernous malformations.

Authors:  Dominique J Verlaan; Sandra B Laurent; Daniel L Rochefort; Christina L Liquori; Douglas A Marchuk; Adrian M Siegel; Guy A Rouleau
Journal:  Ann Neurol       Date:  2004-05       Impact factor: 10.422

8.  Mutations within the MGC4607 gene cause cerebral cavernous malformations.

Authors:  C Denier; S Goutagny; P Labauge; V Krivosic; M Arnoult; A Cousin; A L Benabid; J Comoy; P Frerebeau; B Gilbert; J P Houtteville; M Jan; F Lapierre; H Loiseau; P Menei; P Mercier; J J Moreau; A Nivelon-Chevallier; F Parker; A M Redondo; J M Scarabin; M Tremoulet; M Zerah; J Maciazek; E Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2004-01-22       Impact factor: 11.025

9.  The natural history of familial cavernous malformations: results of an ongoing study.

Authors:  J M Zabramski; T M Wascher; R F Spetzler; B Johnson; J Golfinos; B P Drayer; B Brown; D Rigamonti; G Brown
Journal:  J Neurosurg       Date:  1994-03       Impact factor: 5.115

10.  Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations.

Authors:  Christina L Liquori; Michel J Berg; Adrian M Siegel; Elizabeth Huang; Jon S Zawistowski; T'Prien Stoffer; Dominique Verlaan; Fiyinfolu Balogun; Lori Hughes; Tracey P Leedom; Nicholas W Plummer; Milena Cannella; Vittorio Maglione; Ferdinando Squitieri; Eric W Johnson; Guy A Rouleau; Louis Ptacek; Douglas A Marchuk
Journal:  Am J Hum Genet       Date:  2003-11-17       Impact factor: 11.025

View more
  31 in total

Review 1.  Evaluating strategies for the treatment of cerebral cavernous malformations.

Authors:  Dean Y Li; Kevin J Whitehead
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

2.  Different spectra of genomic deletions within the CCM genes between Italian and American CCM patient cohorts.

Authors:  Christina L Liquori; Silvana Penco; Judith Gault; Tracey P Leedom; Laura Tassi; Teresa Esposito; Issam A Awad; Luigi Frati; Eric W Johnson; Ferdinando Squitieri; Douglas A Marchuk; Fernando Gianfrancesco
Journal:  Neurogenetics       Date:  2007-12-01       Impact factor: 2.660

3.  Familial cerebral cavernous malformations associated with a splice-site CCM2 deletion.

Authors:  Adolfo Jiménez-Huete; Rafael Hortigüela; Elena Riva; Juan Bernar; Pedro Guardado Santervás; Jesús Esteban; Oriol Franch; Miguel Calero
Journal:  J Neurol       Date:  2009-02-09       Impact factor: 4.849

Review 4.  From germline towards somatic mutations in the pathophysiology of vascular anomalies.

Authors:  Nisha Limaye; Laurence M Boon; Miikka Vikkula
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

Review 5.  Genetics of cerebral cavernous malformations: current status and future prospects.

Authors:  H Choquet; L Pawlikowska; M T Lawton; H Kim
Journal:  J Neurosurg Sci       Date:  2015-04-22       Impact factor: 2.279

Review 6.  Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction.

Authors:  Eva Faurobert; Corinne Albiges-Rizo
Journal:  FEBS J       Date:  2010-01-22       Impact factor: 5.542

Review 7.  The pathobiology of vascular malformations: insights from human and model organism genetics.

Authors:  Sarah E Wetzel-Strong; Matthew R Detter; Douglas A Marchuk
Journal:  J Pathol       Date:  2016-12-04       Impact factor: 7.996

8.  Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation.

Authors:  Christopher C Gibson; Weiquan Zhu; Chadwick T Davis; Jay A Bowman-Kirigin; Aubrey C Chan; Jing Ling; Ashley E Walker; Luca Goitre; Simona Delle Monache; Saverio Francesco Retta; Yan-Ting E Shiu; Allie H Grossmann; Kirk R Thomas; Anthony J Donato; Lisa A Lesniewski; Kevin J Whitehead; Dean Y Li
Journal:  Circulation       Date:  2014-12-08       Impact factor: 29.690

9.  Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.

Authors:  Rebecca A Stockton; Robert Shenkar; Issam A Awad; Mark H Ginsberg
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

10.  A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.

Authors:  Axel Pagenstecher; Sonja Stahl; Ulrich Sure; Ute Felbor
Journal:  Hum Mol Genet       Date:  2008-12-16       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.